Intuitive Surgical, Inc. (ISRG) Financial Statements
Intuitive Surgical, Inc. (ISRG) reported trailing twelve-month revenue of $11.6B (up 20.5% year on year) and net income of $3.0B as of 2026-09-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $3.6B.
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
ISRGIntuitive Surgical, Inc.Follow ISRG — free
—
Price chart with a free account
- Market cap
- 156.8B
- P/E TTM
- 54.8
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 20 Jan, in 88 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Sep 26.
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Sep 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.05 | 1.41 | 1.76 | 2.18 | 2.27 | 2.13 | 2.38 | 2.70 | 3.13 | 3.72 | 4.48 | 4.36 | 5.71 | 6.22 | 7.12 | 8.35 | 10.06 | 11.58 | |
| Gross profit | 0.75 | 1.03 | 1.27 | 1.57 | 1.59 | 1.41 | 1.58 | 1.89 | 2.20 | 2.60 | 3.11 | 2.86 | 3.96 | 4.20 | 4.73 | 5.63 | 6.64 | 7.78 | |
| Research & development | 0.10 | 0.12 | 0.14 | 0.17 | 0.17 | 0.18 | 0.20 | 0.24 | 0.33 | 0.42 | 0.56 | 0.60 | 0.67 | 0.88 | 1.00 | 1.15 | 1.31 | 1.49 | |
| Operating income | 0.38 | 0.56 | 0.69 | 0.88 | 0.85 | 0.54 | 0.74 | 0.95 | 1.06 | 1.20 | 1.37 | 1.05 | 1.82 | 1.58 | 1.77 | 2.35 | 2.95 | 3.28 | |
| Pre-tax income | 0.40 | 0.57 | 0.71 | 0.89 | 0.87 | 0.55 | 0.76 | 0.99 | 1.10 | 1.28 | 1.50 | 1.21 | 1.89 | 1.61 | 1.96 | 2.67 | 3.31 | 3.62 | |
| Income tax | 0.16 | 0.19 | 0.21 | 0.24 | 0.20 | 0.13 | 0.17 | 0.25 | 0.43 | 0.15 | 0.12 | 0.14 | 0.16 | 0.26 | 0.14 | 0.34 | 0.43 | 0.65 | |
| Net income | 0.23 | 0.38 | 0.50 | 0.66 | 0.67 | 0.42 | 0.59 | 0.74 | 0.67 | 1.13 | 1.38 | 1.06 | 1.70 | 1.32 | 1.80 | 2.32 | 2.86 | 2.96 | |
| Diluted EPS ($) | 5.93 | 9.47 | 12.32 | 15.98 | 16.73 | 11.11 | 5.18 | 6.26 | 5.77 | 9.49 | 3.85 | 2.94 | 4.66 | 3.65 | 5.03 | 6.42 | 7.87 | 8.26 | |
| Diluted shares (bn) | 0.039 | 0.040 | 0.040 | 0.041 | 0.040 | 0.038 | 0.114 | 0.118 | 0.116 | 0.119 | 0.358 | 0.361 | 0.366 | 0.362 | 0.357 | 0.362 | 0.363 | — |
USD billions · SEC XBRL
Intuitive Surgical, Inc. — questions
- What is Intuitive Surgical, Inc.'s revenue?
- $11.6B over the twelve months to 2026-09-30, up 20.5% year on year, from its 10-Q and 10-K filings.
- What is Intuitive Surgical, Inc.'s net income?
- $3.0B over the twelve months to 2026-09-30.
- What is Intuitive Surgical, Inc.'s free cash flow?
- $3.6B over the twelve months to 2026-09-30.
- What are Intuitive Surgical, Inc.'s diluted earnings per share?
- $8.26 over the twelve months to 2026-09-30.
Every figure on this page comes from Intuitive Surgical, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.